219 related articles for article (PubMed ID: 37760958)
21. Pharmacotherapy of acute lung injury and acute respiratory distress syndrome.
Raghavendran K; Pryhuber GS; Chess PR; Davidson BA; Knight PR; Notter RH
Curr Med Chem; 2008; 15(19):1911-24. PubMed ID: 18691048
[TBL] [Abstract][Full Text] [Related]
22. The clinical usefulness of extravascular lung water and pulmonary vascular permeability index to diagnose and characterize pulmonary edema: a prospective multicenter study on the quantitative differential diagnostic definition for acute lung injury/acute respiratory distress syndrome.
Kushimoto S; Taira Y; Kitazawa Y; Okuchi K; Sakamoto T; Ishikura H; Endo T; Yamanouchi S; Tagami T; Yamaguchi J; Yoshikawa K; Sugita M; Kase Y; Kanemura T; Takahashi H; Kuroki Y; Izumino H; Rinka H; Seo R; Takatori M; Kaneko T; Nakamura T; Irahara T; Saito N; Watanabe A;
Crit Care; 2012 Dec; 16(6):R232. PubMed ID: 23232188
[TBL] [Abstract][Full Text] [Related]
23. Hydrophobic surfactant proteins and their analogues.
Walther FJ; Waring AJ; Sherman MA; Zasadzinski JA; Gordon LM
Neonatology; 2007; 91(4):303-10. PubMed ID: 17575474
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory effect of circulating fibrocytes on injury repair in acute lung injury/acute respiratory distress syndrome mice model.
Tai W; Zhou Z; Zheng B; Li J; Ding J; Wu H; Gao L; Dong Z
J Cell Biochem; 2018 Nov; 119(10):7982-7990. PubMed ID: 29323734
[TBL] [Abstract][Full Text] [Related]
25. Circulating Pulmonary-Originated Epithelial Biomarkers for Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis.
Lin H; Liu Q; Zhao L; Liu Z; Cui H; Li P; Fan H; Guo L
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047065
[TBL] [Abstract][Full Text] [Related]
26. Extracellular vesicles in acute respiratory distress syndrome: Recent developments from bench to bedside.
Quan C; Wang M; Chen H; Zhang H
Int Immunopharmacol; 2021 Nov; 100():108118. PubMed ID: 34492532
[TBL] [Abstract][Full Text] [Related]
27. MicroRNAs: Important Regulatory Molecules in Acute Lung Injury/Acute Respiratory Distress Syndrome.
Lu Q; Yu S; Meng X; Shi M; Huang S; Li J; Zhang J; Liang Y; Ji M; Zhao Y; Fan H
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628354
[TBL] [Abstract][Full Text] [Related]
28. Surfactant therapy for acute lung injury and acute respiratory distress syndrome.
Raghavendran K; Willson D; Notter RH
Crit Care Clin; 2011 Jul; 27(3):525-59. PubMed ID: 21742216
[TBL] [Abstract][Full Text] [Related]
29. A rat model of acute respiratory distress syndrome (ARDS) Part 2, influence of lavage volume, lavage repetition, and therapeutic treatment with rSP-C surfactant.
Häfner D; Germann PG
J Pharmacol Toxicol Methods; 1999; 41(2-3):97-106. PubMed ID: 10598681
[TBL] [Abstract][Full Text] [Related]
30. Intratracheal instillation of alveolar type II cells enhances recovery from acute lung injury in rats.
Guillamat-Prats R; Puig F; Camprubí-Rimblas M; Herrero R; Serrano-Mollar A; Gómez MN; Tijero J; Matthay MA; Blanch L; Artigas A
J Heart Lung Transplant; 2018 Jun; 37(6):782-791. PubMed ID: 29229270
[TBL] [Abstract][Full Text] [Related]
31. Clara cell protein (CC16), a marker of lung epithelial injury, is decreased in plasma and pulmonary edema fluid from patients with acute lung injury.
Kropski JA; Fremont RD; Calfee CS; Ware LB
Chest; 2009 Jun; 135(6):1440-1447. PubMed ID: 19188556
[TBL] [Abstract][Full Text] [Related]
32. Surfactant Protein D Is Associated With Severe Pediatric ARDS, Prolonged Ventilation, and Death in Children With Acute Respiratory Failure.
Dahmer MK; Flori H; Sapru A; Kohne J; Weeks HM; Curley MAQ; Matthay MA; Quasney MW;
Chest; 2020 Sep; 158(3):1027-1035. PubMed ID: 32275979
[TBL] [Abstract][Full Text] [Related]
33. Synthetic lung surfactants containing SP-B and SP-C peptides plus novel phospholipase-resistant lipids or glycerophospholipids.
Notter RH; Gupta R; Schwan AL; Wang Z; Shkoor MG; Walther FJ
PeerJ; 2016; 4():e2635. PubMed ID: 27812430
[TBL] [Abstract][Full Text] [Related]
34. Biomarkers of lung epithelial injury and inflammation distinguish severe sepsis patients with acute respiratory distress syndrome.
Ware LB; Koyama T; Zhao Z; Janz DR; Wickersham N; Bernard GR; May AK; Calfee CS; Matthay MA
Crit Care; 2013 Oct; 17(5):R253. PubMed ID: 24156650
[TBL] [Abstract][Full Text] [Related]
35. Surfactant protein D deficiency increases lung injury during endotoxemia.
King BA; Kingma PS
Am J Respir Cell Mol Biol; 2011 May; 44(5):709-15. PubMed ID: 20639460
[TBL] [Abstract][Full Text] [Related]
36. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS.
Greene KE; Wright JR; Steinberg KP; Ruzinski JT; Caldwell E; Wong WB; Hull W; Whitsett JA; Akino T; Kuroki Y; Nagae H; Hudson LD; Martin TR
Am J Respir Crit Care Med; 1999 Dec; 160(6):1843-50. PubMed ID: 10588595
[TBL] [Abstract][Full Text] [Related]
37. The future of exogenous surfactant therapy.
Willson DF; Notter RH
Respir Care; 2011 Sep; 56(9):1369-86; discussion 1386-8. PubMed ID: 21944686
[TBL] [Abstract][Full Text] [Related]
38. Neuromuscular blockade is associated with the attenuation of biomarkers of epithelial and endothelial injury in patients with moderate-to-severe acute respiratory distress syndrome.
Sottile PD; Albers D; Moss MM
Crit Care; 2018 Mar; 22(1):63. PubMed ID: 29523157
[TBL] [Abstract][Full Text] [Related]
39. [Relationship between alveolar epithelial type II cells and pulmonary surfactant protein A levels in young rats with acute lung injury].
Shu LH; Wei KL; Shang YX; Wu HM; Li J; Han XH; Cai XX; Liu CF; Li JJ; Wang LJ; Shi QX
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Aug; 10(4):504-8. PubMed ID: 18706174
[TBL] [Abstract][Full Text] [Related]
40. Nanomedicine-Based Therapeutics to Combat Acute Lung Injury.
Bian S; Cai H; Cui Y; Liu W; Xiao C
Int J Nanomedicine; 2021; 16():2247-2269. PubMed ID: 33776431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
